<DOC>
	<DOC>NCT00863304</DOC>
	<brief_summary>Test the efficacy and safety of 2 doses of tanezumab compared with naproxen and placebo in patients with osteoarthritis</brief_summary>
	<brief_title>Tanezumab in Osteoarthritis of the Hip or Knee (2)</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Hip</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Osteoarthritis of the hip or knee according to KellgrenLawrence xray grade of 2 pregnancy or intent to become pregnant BMI greater than 39 other severe pain, significant cardiac, neurological or psychiatric disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth factor OA pain arthritis</keyword>
</DOC>